Innovent Biologics, Inc. (1801.HK) HKSE
76.85
-2(-2.54%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 118.55B |
| Enterprise Value | 104.02B |
| P/E Ratio | 140.51 |
| PEG Ratio | 0.16 |
| Price/Sales Ratio | 8.88 |
| Price/Book Ratio | 5.9 |
| Enterprise/Revenue | 7.77 |
| Enterprise/EBITDA | 77.3 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.06 |
| Operating Margin | 0.06 |
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 13.04B |
| Revenue/Share | 7.62 |
| Gross Profit | 10B |
| EBITDA | 1.31B |
| Net Income | 813.57M |
| Diluted EPS | 0.47 |
Balance Sheet
| Total Cash | 18.24B |
| Total Cash/Share | 10.65 |
| Total Debt | 2.82B |
| Total Debt/Equity | 0.15 |
| Current Ratio | 2.62 |
| Book Value Per Share | 11.78 |
Price History
| 52-Week Change | 22.58 |
| 52-Week High | 109.1 |
| 52-Week Low | 68.55 |
| Moving Average 50 Days | 85.93 |
| Moving Average 200 Days | 87.92 |
Statistics
| Average Volume | 15.03M |
| Shares Outstanding | 1.73B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
